Spinal Tech

Life Spine earned FDA 510(k) clearance for its ProLift Pivot expandable spacer system, according to a Jan. 29 news release. 

Stryker is selling its U.S. spinal implant business to investment firm Viscogliosi Brothers, a move that is expected to help the company "better align" its resources, CEO Kevin Lobo said in a Jan. 28 earnings call.

From acquisitions to quarterly updates, here are seven key developments from spine and orthopedic devicemakers since Jan. 22. 

Stryker's CFO Glenn Boehnlein is retiring, and Preston Wells will succeed him as vice president and CFO, according to a Jan. 28 news release.

Stryker plans to sell its U.S. spinal implants business, the company said Jan. 28.

Stryker's net sales grew to $6.4 billion in the fourth quarter of 2024, and full-year revenue increased, according to financial results posted Jan. 28.

The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami (Fla.) Miller School of Medicine is the second U.S. site to join Neuralink's PRIME study, according to a Jan. 27 news release.

NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts, according to a Jan. 27 news release.

Spine navigation, robotics and endoscopic tools are three areas that have seen significant growth within the specialty.

Saluda Medical earned FDA approval for its biomarker-based automated patient programming platform used in spinal cord stimulation.